Association of Community Cancer Centers Honors Researcher and Community Oncologist with National Award

ROCKVILLE, Md. – In recognition of his dedication to cancer research and education, and for promoting the goals of cancer prevention, early detection, and quality cancer treatment, John Powderly II, MD, and CPI (Certified Physician Investigator), president and founder of Carolina BioOncology Institute, Huntersville, N.C., is being honored with the Association of Cancer Care Centers (ACCC’s) 2014 David King Community Clinical Scientist Award.

Dr. Powderly is the only oncologist CPI in the Charlotte, N.C., region. He is an Adjunct Clinical Assistant Professor of Medicine at Duke University and the University of North Carolina, Chapel Hill.

"As a research clinician, Dr. Powderly exemplifies the spirit of Dr. King for whom this national award was named," said ACCC President Virginia T. Vaitones, MSW, OSW-C. "Like Dr. King, Dr. Powderly has spent his career championing the value of the community clinical oncology program and raising awareness of the role of clinical research in the community cancer setting."

ACCC's prestigious award is named after David K. King, MD, FACP, who died after a brief battle with cancer. Dr. King had a long history with the Association of Cancer Care Centers, serving in many capacities—president, chair of ACCC's Annual Presidents Retreat, and co-chair of ACCC's Reimbursement Committee. Dr. King dedicated his professional career to caring for individuals with cancer and advocating for access to quality care, the Community Clinical Oncology Program, and the value of clinical research in the community environment."I am honored to have received this award," said Dr. Powderly. "To be recognized for our hard work in fighting cancer and providing access to immunotherapy trials to patients in the Charlotte area is a wonderful validation of the clinic’s mission.”

David King Community Clinical Scientist Award winners become lifetime members of the ACCC National Academy of Community Oncology Scientists, which serves as a valuable resource to ACCC, the National Cancer Institute (NCI), pharmaceutical companies, and other organizations involved in community cancer research.

The award presentation will take place on April 2, during the ACCC 40th Annual National Meeting, being held March 31 to April 2, at the Hyatt Regency Crystal City, Arlington, Va.